| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0091-6749(91)90420-S |
| P698 | PubMed publication ID | 2026848 |
| P2093 | author name string | E W Gelfand | |
| B D Mazer | |||
| P433 | issue | 5 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 976-983 | |
| P577 | publication date | 1991-05-01 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma | |
| P478 | volume | 87 |
| Q33624396 | Age related IgG subclass concentrations in asthma |
| Q37713772 | Allergen-specific IgG as a mediator of allergy inhibition: Lessons from mother to child |
| Q77324301 | Alternative non-steroidal anti-inflammatory therapy for asthma |
| Q35258478 | Anti-inflammatory drugs in the treatment of allergic disease |
| Q41114249 | Appropriate therapeutic use of immunoglobulin |
| Q33575466 | Asthma that is unresponsive to usual care |
| Q33930453 | Asthma--the changing face of drug therapy |
| Q36215826 | Asthma. A role for IVIG therapy? |
| Q37901520 | Bringing immunoglobulin knowledge up to date: how should we treat today? |
| Q33976334 | Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group |
| Q34273468 | Children with difficult asthma: a practical approach |
| Q36627669 | Corticosteroid-sparing effect of chromoglycate sodium and nedocromil |
| Q33572099 | Criteria for the appropriate drug utilisation of immunoglobulin |
| Q41611587 | Diagnosis and management of steroid-resistant asthma |
| Q33634099 | Difficult asthma: beyond the guidelines |
| Q53932125 | Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial. |
| Q35563703 | Effects of high dose intravenous immunoglobulin in two severe corticosteroid insensitive asthmatic patients. |
| Q45977274 | High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. |
| Q33500211 | Human intravenous immunoglobulin therapy. |
| Q41925716 | Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma |
| Q81203088 | Immunotherapy |
| Q30252123 | Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms |
| Q71825756 | In vitro synthesis of human IgE is suppressed by human IgG |
| Q35278935 | Intravenous immunoglobulin for cystic fibrosis lung disease: a case series of 16 children |
| Q33497629 | Intravenous immunoglobulin in rheumatic disease |
| Q77398105 | Intravenous immunoglobulin inhibits IgE production in human B lymphocytes |
| Q54103259 | Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin. |
| Q33599184 | Newer therapeutic agents for asthma |
| Q54149984 | Non-steroidal anti-inflammatory therapy for bronchial asthma. |
| Q35331126 | Pharmacotherapy of childhood asthma. An inflammatory disease |
| Q52536215 | Possible dual role of anti-idiotypic antibodies in combined passive and active immunotherapy in honeybee sting allergy. |
| Q40754435 | Report of an international workshop on risk and safety of asthma therapy |
| Q35566002 | Severe Asthma |
| Q55664880 | Severe small airways disease resistant to medical treatment in a child with cystic fibrosis. |
| Q77177693 | Shortage of intravenous immunoglobulin |
| Q41229313 | Steroid-resistant asthma: evaluation and management |
| Q37110663 | T cells expressing variable elements of T-cell receptor beta 8 and beta 2 chain regulate murine IgE production |
| Q38268922 | The protective role of immunoglobulins in fungal infections and inflammation |
| Q33708505 | The role of immunoglobulin therapy in allergic diseases |
| Q34661825 | Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids. |
| Q80953233 | [Immunomodulatory effects of intravenous immunoglobulins] |
Search more.